Article info

Download PDFPDF

Response to: ‘Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson et al’ by Ebbo et al
Free

Authors

  1. Correspondence to Rachel S Simpson, Toronto Allergists, Toronto, Ontario, Canada; rachel.simpson{at}queensu.ca
View Full Text

Citation

Simpson RS, Lee JK
Response to: ‘Correspondence on: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson et al’ by Ebbo et al

Publication history

  • Received February 19, 2020
  • Accepted February 20, 2020
  • First published March 10, 2020.
Online issue publication 
January 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.